Summary

Lack of information on products entering the United States limits the effectiveness of the Food and Drug Administration's (FDA) efforts to regulate imported products before they are sold to the American public.

FDA does not maintain enough specific information on the types and volume of imports to know whether all the various imported products are inspected. Without such data, the agency cannot determine how effective its import surveillance is nor can it assess the extent that imports comply with regulations.